These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11303584)

  • 1. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
    Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
    Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
    Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
    Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
    Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer of the cervix, papillomavirus, contraception and tobacco].
    Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
    Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
    Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
    Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus.
    Serwadda D; Wawer MJ; Shah KV; Sewankambo NK; Daniel R; Li C; Lorincz A; Meehan MP; Wabwire-Mangen F; Gray RH
    J Infect Dis; 1999 Oct; 180(4):1316-9. PubMed ID: 10479163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma.
    Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma.
    Struijk L; Hall L; van der Meijden E; Wanningen P; Bavinck JN; Neale R; Green AC; Ter Schegget J; Feltkamp MC
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):529-35. PubMed ID: 16537712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Hansson BG; Rosenquist K; Antonsson A; Wennerberg J; Schildt EB; Bladström A; Andersson G
    Acta Otolaryngol; 2005 Dec; 125(12):1337-44. PubMed ID: 16303684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
    Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
    J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.